ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Amivantamab plus chemotherapy vs chemotherapy as a first-line treatment among Asian patients with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer (NSCLC): PAPILLON subgroup analysis

Zhou, C.; Tang, K.; Liu, B.; Kim, S-W.; Kitazono, S.; Ono, A.; Thiagarajan, M.; Hung, J-Y.; Boyer, M.; Xie, J.; Bhattacharya, A.; Baig, M.; Agrawal, T.; Knoblauch, R. E.; Cho, B. C.哈尔滨医科大学; 同济大学; 中山大学; 1
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)2023-11DOI: 10.1016/j.annonc.2023.10.592
8阅读
引用收藏
分享
相关
加载中…
  • Amivantamab plus lazertinib vs osimertinib as first-line treatment among Asian patients with EGFR-mutated, advanced non-small cell lung cancer (NSCLC): MARIPOSA subgroup analysis
    Lu, S.; Cho, B. C.; Lee, J-S.; Lee, S-H.; Danchaivijitr, P.; Liu, B.; Alip, A.; Xiong, H.; How, S. H.; Chang, G-C.; Yang, J. C-H.; Yoshioka, H.; Xia, K.; Martinez, M.; Bauml, J. M.; Sethi, S.; Hayashi, H.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 2023-12-01 To 2023-12-03.
  • Amivantamab plus lazertinib vs osimertinib as first-line treatment in patients with EGFR-mutated, advanced nonsmall cell lung cancer (NSCLC): Primary results from MARIPOSA, a phase III, global, randomized, controlled trial
    Cho, B. C.; Felip, E.; Spira, A. I.; Girard, N.; Lee, J. S.; Lee, S. H.; Ostapenko, Y. V.; Danchaivijitr, P.; Liu, B.; Alip, A.; Korbenfeld, E. P.; Dias, J.; Sun, T.; Martinez, M.; Bauml, J. M.; Shreeve, M.; Sethi, S.; Knoblauch, R. E.; Hayashi, H.; Lu, S.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.被引 2
  • Efficacy of various types of chemotherapy for advanced non-small cell lung cancer with EGFR exon 20 in-frame insertions.
    Tang, Haibo; Li, Xiaoning; Cai, Jianhong; Wu, Xiaomin; Zheng, Yating; Huang, MengliVirtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2021-06-04 To 2021-06-08.
查看全部 →

会议信息

会议名称
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)
会议日期
2023-12-01 至 2023-12-03
论文集名
ANNALS OF ONCOLOGY
发表日期
2023-11
起止页码
S1668-S1669
DOI
10.1016/j.annonc.2023.10.592
资助标注
Janssen Pharmaceuticals
收录
ISTP · SCIE

作者

  • Z

    Zhou, C. (第一作者)

    shanghai pulm hosp · tongji univ

  • T

    Tang, K.

    1 · sun yat sen univ

查看全部 15 位作者收起作者
  • L

    Liu, B.

    harbin med univ

  • K

    Kim, S-W.

  • K

    Kitazono, S.

    canc inst hosp

  • O

    Ono, A.

  • T

    Thiagarajan, M.

  • H

    Hung, J-Y.

  • B

    Boyer, M.

  • X

    Xie, J.

  • B

    Bhattacharya, A.

  • B

    Baig, M.

  • A

    Agrawal, T.

  • K

    Knoblauch, R. E.

  • C

    Cho, B. C.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417